BIOMERICA INC
For the period ended May 31, 2026. Filed Aug 31, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Aug 31, 2026
BMRA$1.48-4.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
INDEX TO FINANCIAL STATEMENTS
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
| Report of Independent Registered Public Accounting Firm (PCAOB ID 0200) | FS-2 – FS-3 |
|---|---|
| CONSOLIDATED FINANCIAL STATEMENTS | |
| Consolidated Balance Sheets as of May 31, 2026 and 2025 | FS-4 |
| Consolidated Statements of Operations and Comprehensive Loss for the Years Ended May 31, 2026 and 2025 | FS-5 |
| Consolidated Statements of Shareholders’ Equity for the Years Ended May 31, 2026 and 2025 | FS-6 |
| Consolidated Statements of Cash Flows for the Years Ended May 31, 2026 and 2025 | FS-7 |
| Notes to Consolidated Financial Statements | FS-8 – FS-20 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.